Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis

M. Furue, K. Yamamura, M. Kido-Nakahara, T. Nakahara, Y. Fukui

研究成果: Contribution to journalReview article査読

84 被引用数 (Scopus)

抄録

Atopic dermatitis (AD) is a chronic or chronically relapsing, eczematous, severely pruritic skin disorder associated with skin barrier dysfunction. The lesional skin of AD exhibits T helper 2 (TH2)-deviated immune reactions. Interleukin-31 (IL-31), preferentially produced from TH2 cells, is a potent pruritogenic cytokine, and its systemic and local administration induces scratching behavior in rodents, dogs and monkeys. Recent clinical trials have revealed that administration of an anti-IL-31 receptor antibody significantly alleviates pruritus in patients with AD. In this review, we summarize recent topics related to IL-31 and its receptor with special references to atopic itch.

本文言語英語
ページ(範囲)29-36
ページ数8
ジャーナルAllergy: European Journal of Allergy and Clinical Immunology
73
1
DOI
出版ステータス出版済み - 1 2018

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

フィンガープリント 「Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル